The Experts below are selected from a list of 10341 Experts worldwide ranked by ideXlab platform
Klaus Vedder - One of the best experts on this subject based on the ideXlab platform.
-
International Standardisation of IT Security
Lecture Notes in Computer Science, 1998Co-Authors: Klaus VedderAbstract:This paper discusses the standards and activities of the ISO/IEC committee SC 27 Information technology - Security techniques, which develops general security mechanisms, guidelines and criteria for IT security, and of the European Telecommunications Standards Institute, which specifies security services as part of the Standardisation of telecommunication systems.
-
State of the Art in Applied Cryptography - International Standardisation of IT Security
State of the Art in Applied Cryptography, 1998Co-Authors: Klaus VedderAbstract:This paper discusses the standards and activities of the ISO/IEC committee SC 27 "Information technology - Security techniques", which develops general security mechanisms, guidelines and criteria for IT security, and of the European Telecommunications Standards Institute, which specifies security services as part of the Standardisation of telecommunication systems.
Joseph Watine - One of the best experts on this subject based on the ideXlab platform.
-
Translations of the "Evidence-Based Medicine" concept in different languages: is it time for International Standardisation?
Clinical Chemistry and Laboratory Medicine, 2010Co-Authors: Joseph WatineAbstract:Although the concept of Evidence-Based Medicine (EBM) is quite popular among English speaking physicians, it still needs to be adopted by an overwhelming majority of health care professionals in countries where English is not familiar. Thus, this concept can be translated in many different, and potentially misleading, ways. This is regrettable because the concept is, at least potentially, a very useful one. As an illustration, I have compiled some of the French translations of EBM that are currently in use in French speaking countries, and indicated briefly how most of these translations (except for one) are bound to be misleading. Many of these misleading translations currently in use strongly suggest that it is time for an International Standardisation of the translations of EBM in different languages.
Gérard Rivière - One of the best experts on this subject based on the ideXlab platform.
-
European and International Standardisation progress in the field of engineered nanoparticles
Inhalation Toxicology, 2009Co-Authors: Gérard RivièreAbstract:CEN-STAR supports researchers to be experts in standardization committees in new challenging issues: Standardization needs to reach consensus from new knowledge. In Europe, pre-normative and co-normative research can be supported financially by the FP7 for research. The area of nanoscience and nanotechnology is developing new standards in Europe within the CEN/TC 352, at the International level at the ISO/TC 229. Particular works are about measurement methods and tests for toxicity at the nanoscale. Some activities are done within the Organisation for Economic Cooperation and Development (OECD) and in some other parts of the world, such as the Asian Nano-Forum and the National Institute of Standards and Technology (NIST) in the United States. Main items for standardization include: definition terminology; metrology instrumentation, reference methods, and materials; measurement methods for applications (physical, chemical, material, electronics); and measurement methods for interface in health, environment...
-
European and International Standardisation progress in the field of engineered nanoparticles.
Inhalation toxicology, 2009Co-Authors: Gérard RivièreAbstract:CEN-STAR supports researchers to be experts in standardization committees in new challenging issues: Standardization needs to reach consensus from new knowledge. In Europe, pre-normative and co-normative research can be supported financially by the FP7 for research. The area of nanoscience and nanotechnology is developing new standards in Europe within the CEN/TC 352, at the International level at the ISO/TC 229. Particular works are about measurement methods and tests for toxicity at the nanoscale. Some activities are done within the Organisation for Economic Cooperation and Development (OECD) and in some other parts of the world, such as the Asian Nano-Forum and the National Institute of Standards and Technology (NIST) in the United States. Main items for standardization include: definition terminology; metrology instrumentation, reference methods, and materials; measurement methods for applications (physical, chemical, material, electronics); and measurement methods for interface in health, environment, and safety. For toxicity at the nanoscale, particular issues have to be resolved, such as: reproducibility of experiments; reference protocols and use of quality management standards for research (ISO 9001); and intercomparability of results following "round robin" tests. The little information about standardization in nanotechnology in Europe includes the Code of Conduct for Responsible Nanosciences and Nanotechnologies Research and the European Commission mandate to CEN/TC 352, as well as the European Union (EU) projects NanoStrand, NanoInteract, NanoImpactNet, and others.
Ian Goodall - One of the best experts on this subject based on the ideXlab platform.
-
HbA1c Standardisation: History, Science and Politics
The Clinical biochemist. Reviews, 2007Co-Authors: W. Garry John, Andrea Mosca, Cas Weykamp, Ian GoodallAbstract:Significant analytical improvements have occurred since glycated haemoglobin (GHb), measured as total HbA1, was first used in routine clinical laboratories around 1977. Following the publication of the Diabetes Control and Complications Trial (DCCT) study in 1993 the issue of International Standardisation became an important objective for scientists and clinicians. The lack of International Standardisation led several countries to develop national Standardisation programs. The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Working Group on Standardisation of HbA1c established a true International reference measurement system for HbA1c and the successful preparation of pure HbA1c calibration material that should lead to further improvements in inter-method and inter-laboratory variability. Reporting of HbA1c has been agreed using the units of mmol/mol (IFCC) and percent (National Glycohemoglobin Standardization Program, NGSP).
Cas Weykamp - One of the best experts on this subject based on the ideXlab platform.
-
HbA1c Standardisation: History, Science and Politics
The Clinical biochemist. Reviews, 2007Co-Authors: W. Garry John, Andrea Mosca, Cas Weykamp, Ian GoodallAbstract:Significant analytical improvements have occurred since glycated haemoglobin (GHb), measured as total HbA1, was first used in routine clinical laboratories around 1977. Following the publication of the Diabetes Control and Complications Trial (DCCT) study in 1993 the issue of International Standardisation became an important objective for scientists and clinicians. The lack of International Standardisation led several countries to develop national Standardisation programs. The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Working Group on Standardisation of HbA1c established a true International reference measurement system for HbA1c and the successful preparation of pure HbA1c calibration material that should lead to further improvements in inter-method and inter-laboratory variability. Reporting of HbA1c has been agreed using the units of mmol/mol (IFCC) and percent (National Glycohemoglobin Standardization Program, NGSP).
-
preparation of a candidate primary reference material for the International Standardisation of hba1c determinations
Clinical Chemistry and Laboratory Medicine, 1998Co-Authors: Andreas Finke, Cas Weykamp, Uwe Kobold, W Hoelzel, Ko Miedema, Janolof JeppssoAbstract:We prepared a candidate primary reference material for the forthcoming International Standardisation of b-N-terminal glycated hemoglobin A measurements. It consists of well-defined mixtures of purified b-N-terminal glycated hemoglobin A and non-glycated hemoglobin A. First, b-N-terminal glycated hemoglobin A and nonglycated hemoglobin A were isolated, purified to homogeneity, and characterised. The techniques used were cation exchange and affinity chromatography for the purification, and high performance liquid chromatography, capillary isoelectric focusing, electrospray ionisation mass spectrometry, and peptide mapping for the characterisation. Hemoglobins from blood of healthy, non-diabetic volunteers were obtained with a purity of >99.5 % for non-glycated hemoglobin A and of >98.5% for b-N-terminal glycated hemoglobin A. However, results from peptide mapping indicate that the bN-terminal glycated hemoglobin A preparations still contain some non-b-N-terminal glycated hemoglobins, co-eluting with b-N-terminal glycated hemoglobin A. The exact content of b-N-terminal glycated hemoglobin A in these preparations could be determined by a procedure consisting of standard addition, enzymatic cleavage and quantification of the resulting b-Nterminal peptides to be in the range from 95 ‐ 97.5%. Since the b-N-terminal glycated hemoglobin A and non-glycated hemoglobin A content could be exactly determined in the materials prepared, mixtures of both components could be successfully used to calibrate the candidate reference methods.